Bill Sponsor
Senate Bill 585
117th Congress(2021-2022)
United States Anti-Doping Agency Reauthorization Act of 2021
Introduced
Introduced
Introduced in Senate on Mar 3, 2021
Overview
Text
Introduced
Mar 3, 2021
Latest Action
Mar 3, 2021
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
585
Congress
117
Policy Area
Sports and Recreation
Sports and Recreation
Primary focus of measure is youth, amateur, and professional athletics; outdoor recreation; sports and recreation facilities. Measures concerning recreation areas may fall under Public Lands and Natural Resources policy area.
Sponsorship by Party
Republican
Kansas
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary

United States Anti-Doping Agency Reauthorization Act of 2021

This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2030.

The bill adds requirements that USADA

  • be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within the jurisdiction of the United States; and
  • promote a positive youth sport experience by using a portion of its funding to provide educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports.

The bill requires any action taken by USADA to enforce a policy, procedure, or requirement against a person with respect to a violation of federal law, including an investigation, disciplinary action, sanction, or any other administrative action, to be carried out in a manner that provides due process protection.

The Department of Justice, the Department of Homeland Security, and the Food and Drug Administration must provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.

Text (1)
Actions (2)
03/03/2021
Read twice and referred to the Committee on Commerce, Science, and Transportation.
03/03/2021
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:47:48 PM